The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 17, 2026
Snapshot (as of Aug 17, 2026): Vanguard Health Care Fund Investor Shares (VGHCX) pays a $12.98 annual dividend ($3.24 quarterly), yielding 6.22% at $208.73/share. Next ex-dividend date 2026-03-30. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 6.22%
Annual Dividend: $12.98 per share
Ex-Dividend Date: 2026-03-30
Dividend Frequency: quarterly
Sector: Financial Services
Years of Dividend History: 25
The Vanguard Health Care Fund Investor Shares dividend comes from an actively managed fund with over 25 years of history, holding pharmaceutical developers, medical equipment manufacturers, and research institutions across global healthcare markets. The current yield stands at 6.23%, with a trailing annual dividend rate of $12.9752 per share paid quarterly. The next ex-dividend date is March 30, 2026. With a beta of 0.544, VGHCX moves at roughly half the volatility of the broader market, which suits income-focused investors who want healthcare exposure without the full swing of sector-concentrated risk.
Vanguard Health Care Fund Investor Shares pays out dividends as a fund, making the payout ratio not applicable (fund/ETF). Vanguard Health Care Fund Investor Shares dividend safety rests on the underlying portfolio's ability to generate returns across pharmaceutical, medical equipment, and research holdings rather than on a single company's earnings. The key pressure point is sector concentration: all holdings sit within healthcare, so a broad downturn in that industry directly affects the fund's capacity to sustain current distribution levels.
Vanguard Health Care Fund Investor Shares dividend history shows a CAGR of 7.2% per year from 1998 to 2024. Per-share payments grew from $3.9200 in 1998 to $23.7995 in 2024 (2025 and 2026 figures are partial years and excluded from the CAGR calculation). The largest annual increase in the window was 120.5% in 2013. The data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -8.8% | $11.59 (2022) | $8.80 (2025) |
| 5-Year | -12.5% | $17.18 (2020) | $8.80 (2025) |
| 10-Year | -6.9% | $17.97 (2015) | $8.80 (2025) |
VGHCX fits income-focused investors who want broad exposure to global healthcare, from pharmaceuticals to medical equipment, paired with a high current yield. The yield is classified as high (above 4%), currently at 6.23%, though that sits below the 5-year average of 7.49%, meaning recent pricing has compressed the yield relative to its own history. Annual distributions have been volatile, with swings exceeding 50% in some years, so investors accept meaningful year-to-year income variability. What they gain is a 7.2% long-run growth rate in distributions and a low-beta fund that dampens broader market swings. The trade-off is unpredictability in any given year's payout.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-30 | $7.6578 |
| 2025-12-19 | $5.3174 |
| 2025-03-28 | $3.4819 |
| 2024-12-20 | $17.6418 |
| 2024-03-27 | $6.1577 |
| 2023-12-27 | $8.2529 |
| 2023-03-28 | $6.7329 |
| 2022-12-28 | $3.8742 |
| 2022-03-28 | $7.7176 |
| 2021-12-29 | $15.5479 |
| Year | Total Dividends |
|---|---|
| 2026 | $7.6578 |
| 2025 | $8.7993 |
| 2024 | $23.7995 |
| 2023 | $14.9858 |
| 2022 | $11.5918 |
Project income from VGHCX with the VGHCX dividend calculator or track your full portfolio with the dividend tracker.